NDLR 2020 has been postponed until 9 – 11 March 2021

 

Express Your Interest

Join our mailing list to be kept up to date
with information on the Meeting.

Key Dates

Call for abstracts: 24 June 2020

Abstract submission deadline: 27 November 2020

Author/early bird registration deadline: 29 January 2021

Meeting dates: 9 – 11 March 2021

Invited Speakers

We have a compelling line up of invited speakers for 2021.

Click the link to see who will be presenting.

Welcome

The Scientific and Organising Committees invite you to participate in the 8th New Directions in Leukaemia Research (NDLR) meeting to be held at the Brisbane Convention and Exhibition Centre in Queensland, Australia, from Tuesday 9 March to Thursday 11 March, 2021.

The goal of the NDLR conferences is to bring together scientists and clinicians to discuss emerging paradigms and breakthroughs at the forefront of leukaemia research and treatment, from the molecular basis of leukaemia to new therapies emerging in the clinic.

As one of the premier international leukaemia conferences, NDLR 2021 will again bring together early-career investigators and senior scientists. Attendees will hear of recent findings in basic and translational research through interaction with local and international experts, allowing new collaborations to be forged.

Leukaemia research has undergone an unprecedented revolution in recent years and this is beginning to deliver a real and significant impact in the clinic. The biennial NDLR conferences offer a unique opportunity for scientists and clinicians to keep pace with such a rapidly evolving field.

We look forward to seeing you at NDLR 2021.

Associate Professors Matthew McCormack & Ross Dickins (co-chairs)

NDLR 2018 Delegates

Thank you to our Sponsors

 

NDLR 2021 Meeting Supporter

 

 

Principal Sponsors

Astrazeneca

 

Gold Sponsor

Silver Sponsor

Bronze Sponsors

                       

 

Scientific Poster and Notepad & Pen Sponsor